Overview：
We developed a groundbreaking, cost-effective, protein expression plant-based platform to produce growth factors (GFs) for use in cultivated meat (CM).

Advantages of our technology：
Existing production technologies and infrastructures are not suitable for providing growth factors in sufficient production volumes and at costs low enough to support commodity-scale production of cultivated meat. By using tobacco plants grown in open fields as self-sustained, renewable energy-driven “bioreactors”, combined with a novel purification method, our technology enables unparalleled production scale of complex proteins. Our disruptive technology overcomes the limitations of traditional methods and places the cost of GF production at <1$/gram.
<BioBetter's Promotion Video>https://www.youtube.com/watch?v=dr53OS_pVM8

Our business model：
Cell-Ag industry aims to replace animal products (such as meat, diary, eggs, seafood, leather and many more) currently amounting over $3T. Conservative market assessments such as McKinsey’s estimate that the cultivated meat market by itself will reach $25B by 2030. BioBetter is positioned to become the preferred solution for major CM companies. The company also aims to form strategic partnerships with major media suppliers and distributors.

Our aim for business：
[Target department / division/ companies]
R&D, Business Development, and executive teams

[Principle Objective of exhibiting at GIF]
To find joint venture partners
To find PoC partners
To find users

URL：
https://biobetter.bio/